Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy
Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy
复制标题
DOI:
10.1253/circj.69.711
复制
发表时间:
2005-06-01
影响因子:
3.3
通讯作者:
Horie, M
中科院分区:
文献类型:
--
作者:
Nakae, I;Mitsunami, K;Horie, M
Background Previous P-31 magnetic resonance spectroscopy (MRS) studies demonstrated that the myocardial phosphocreatine-to-ATP ratio offered important information concerning the degree of dysfunction and prognosis in patients with cardiomyopathy. In the present study, we investigated total creatine (CR) levels in various diseased hearts using H-1 MRS.Methods and Results Fourteeen patients with the following conditions were examined: cardiac amyloidosis (n=2); hypertensive heart disease (4); valvular disease (2); hypertrophic cardiomyopathy (2); dilated cardiomyopathy (2); restrictive cardiomyopathy (1); and post-operative atrial septal defect (1). Myocardial CR was measured using 1H MRS with point-resolved spectroscopy localization. Overall, myocardial CR levels in diseased hearts were significantly lower than those in the control group [16.5 +/- 6.0 (n=14) vs 27.1 +/- 3.2 mu mol/g (n=10), p < 0.001]. There was a positive correlation between myocardial CR and left ventricular ejection fraction (42.9 +/- 13.8%, range 19.5-69.1%) despite the different mechanisms of cardiac dysfunction (r=0.60, p < 0.05). Myocardial CR levels in patients who were hospitalized due to heart failure within 1 year were significantly lower than those in other patients [11.3 +/- 1.0 (n=4) vs 18.6 +/- 5.9 mu mol/g (n=10), p < 0.05].Conclusions Noninvasive measurement of myocardial CR using H-1 MRS may be valuable in the assessment of disease severity and prediction of clinical course in various forms of heart disease.